Reporting Drugs Adverse Reactions
Pharmacovigilance is the monitoring, evaluation, prevention and management of the adverse effects risk resulting from the use of medicines. In Morocco, it is exercised permanently, before and after the marketing of medicines, and constitutes an essential element of the safety control of medicines.
Through the collection, recording and scientific evaluation of information related to adverse reactions associated with the use of our medicines, SOLUDIA MAGHREB participates in the protection of human health.
SOLUDIA MAGHREB pharmacovigilance unit is in contact with the health authorities, in particular the Moroccan Pharmacovigilance Centre (CMPV). This unit proposes measures to reduce any risks associated with the use of our medicines and promotes their proper use.
Pharmacovigilance unit SOLUDIA MAGHREB
email: pharmacovigilance@soludia.ma
Phone : +212 537 845 986/ +212 537 844 242
Fax : +212 537 845 987
Moroccan Pharmacovigilance Centre
Emergency phone : +212 5 37 68 64 64
Or Eco N° : 0801 000 180
Fax : +212 5 37 77 71 79